QQ客服 官方微博 反馈留言

	Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future
	Huang, Yi; Gu, Zili; Fan, Yang; Zhai, Guangxi; Zhao, Xiaogang; Sun, Qifeng; Shi, Yanbin; Lin, Guimei
刊名	PURINERGIC SIGNALLING
	2019
卷号	15期号:1页码:53-67
关键词	Immunosuppression Poor prognosis Adenosine Targeted nanoparticles
DOI	10.1007/s11302-018-9641-4
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4544548
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, 44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R Chin
推荐引用方式 GB/T 7714	Huang, Yi,Gu, Zili,Fan, Yang,et al. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future[J]. PURINERGIC SIGNALLING,2019,15(1):53-67.
APA	Huang, Yi.,Gu, Zili.,Fan, Yang.,Zhai, Guangxi.,Zhao, Xiaogang.,...&Lin, Guimei.(2019).Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future.PURINERGIC SIGNALLING,15(1),53-67.
MLA	Huang, Yi,et al."Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future".PURINERGIC SIGNALLING 15.1(2019):53-67.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。